Related Experiment Video
Updated: Jul 11, 2025

09:08
Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies
Published on: May 24, 2021
5.9K
Hydrogel-Embedded Precision-Cut Lung Slices Model Lung Cancer Premalignancy Ex Vivo
Rachel Blomberg1, Kayla Sompel2, Caroline Hauer2
1Department of Bioengineering, University of Colorado, Denver |Anschutz, Aurora, CO, 80045, USA.
Advanced Healthcare Materials
|November 13, 2023
Summary
A new lung cancer model using engineered lung tissue in a hydrogel effectively mimics premalignant lesions. This model aids in studying lung cancer development and testing chemoprevention strategies.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Pulmonology
Background:
- Lung cancer remains a leading cause of cancer mortality globally.
- Existing research models, like rodent studies, present significant limitations in time, cost, and scale.
- A substantial portion of lung cancer diagnoses occur in former smokers, highlighting the need for better prevention and treatment research.
Purpose of the Study:
- To develop an advanced in vitro model for studying lung cancer premalignancy and chemoprevention.
- To create a more efficient and relevant alternative to traditional animal models for lung cancer research.
Main Methods:
- Precision-cut lung slices (PCLS) were embedded in a specialized hydrogel designed to support tissue viability and promote early cancer phenotypes.
- The hydrogel-embedded PCLS were exposed to vinyl carbamate, a carcinogen found in cigarette smoke, to induce premalignant changes.
- The model was assessed using analyses of proliferation, gene expression, histology, tissue stiffness, and cellular content over six weeks.
- Murine PCLS results were validated using human PCLS to confirm the model's applicability to human lung tissue.
Main Results:
- Vinyl carbamate successfully induced premalignant lesions in the hydrogel-embedded PCLS, exhibiting a mixed adenoma/squamous phenotype.
- The engineered hydrogel extended PCLS viability for up to six weeks, allowing for extended study periods.
- Chemoprevention agents demonstrated efficacy by diffusing through the hydrogel and inducing measurable tissue-level changes.
- Validation with human PCLS confirmed increased proliferation and gene expression patterns indicative of premalignant lesions.
Conclusions:
- The developed tissue-engineered model provides a robust platform for investigating the early stages of lung cancer (carcinogenesis).
- This ex vivo model facilitates the screening and evaluation of potential chemoprevention agents.
- The model's success with both murine and human lung tissue paves the way for more sophisticated and predictive lung cancer research.

